* The issuer did not co-operate; based on best available information.
Rating Rationale
Acuité has reaffirmed the long-term rating to ‘ACUITE D’ (read as ACUITE D) and the short term rating to ‘ACUITE D’ (read as ACUITE D) on the Rs. 12.00 crore bank facilities of Captab Biotec Unit II. The rating continues to be flagged as “Issuer Not-Cooperating” and is based on the best available information.
About the Company
Captab Biotec Unit II was established in 2015 as a partnership firm by Mr. Shubham Goel and Mr. Kapish Goel. The firm manufactures formulations - generics including capsules, tablets and dry syrup along with injectable. The day-to-day operations are led by Mr. Sushil Goel and Mr. Pawan Goel. The manufacturing facility is located at Baddi, Himachal Pradesh.
Unsupported Rating
Not Applicable
Non-cooperation by the issuer/borrower:
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and non-cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is, therefore, being flagged as “Issuer not-cooperating”, in line with prevailing SEBI regulations and Acuité’s policies.
Limitation regarding information availability
Rating Sensitivity
"No information provided by the issuer / available for Acuite to comment upon."
Liquidity Position
"No information provided by the issuer / available for Acuite to comment upon."